Dividendos de Grand Pharmaceutical Group
Dividendo controles de criterios 3/6
Grand Pharmaceutical Group es una empresa que paga dividendos con una rentabilidad actual de 5.34% que está bien cubierta por los beneficios.
Información clave
5.3%
Rentabilidad por dividendo
49%
Ratio de pago
| Rentabilidad media de la industria | 3.3% |
| Próxima fecha de pago de dividendos | n/a |
| Fecha ex dividendo | n/a |
| Dividendo por acción | n/a |
| Beneficios por acción | HK$0.54 |
| Rentabilidad por dividendo prevista a 3 años | 6.8% |
Últimas actualizaciones de dividendos
Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year
Jun 05
Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Apr 25Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25Recent updates
Grand Pharmaceutical Group (HKG:512) Is Paying Out A Larger Dividend Than Last Year
Jun 05Market Participants Recognise Grand Pharmaceutical Group Limited's (HKG:512) Earnings
May 22Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Apr 25Grand Pharmaceutical Group (HKG:512) Will Pay A Larger Dividend Than Last Year At HK$0.26
Mar 25We Think Grand Pharmaceutical Group (HKG:512) Can Stay On Top Of Its Debt
Oct 20Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Sep 26Grand Pharmaceutical Group's (HKG:512) Dividend Will Be Increased To HK$0.14
Jun 04Is Grand Pharmaceutical Group (HKG:512) A Risky Investment?
May 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Nov 21Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 43% Discount?
Sep 05Grand Pharmaceutical Group (HKG:512) Seems To Use Debt Quite Sensibly
Aug 16Here's Why We Think Grand Pharmaceutical Group (HKG:512) Is Well Worth Watching
Jul 28Grand Pharmaceutical Group's (HKG:512) Dividend Will Be HK$0.11
May 29Is Grand Pharmaceutical Group Limited (HKG:512) Trading At A 45% Discount?
Apr 08Grand Pharmaceutical Group (HKG:512) Has A Rock Solid Balance Sheet
Mar 22If You Like EPS Growth Then Check Out Grand Pharmaceutical Group (HKG:512) Before It's Too Late
Jan 24These 4 Measures Indicate That Grand Pharmaceutical Group (HKG:512) Is Using Debt Safely
Dec 13Grand Pharmaceutical Group Limited's (HKG:512) Intrinsic Value Is Potentially 45% Above Its Share Price
Nov 27With EPS Growth And More, China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Interesting
Oct 25China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Seems To Use Debt Rather Sparingly
Sep 01Do China Grand Pharmaceutical and Healthcare Holdings's (HKG:512) Earnings Warrant Your Attention?
Jul 12We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Can Stay On Top Of Its Debt
Apr 26Calculating The Fair Value Of China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512)
Apr 08Here's Why We Think China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Is Well Worth Watching
Mar 24If You Had Bought China Grand Pharmaceutical and Healthcare Holdings (HKG:512) Shares Five Years Ago You'd Have Earned 332% Returns
Mar 11Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: Aunque el pago de dividendos se ha mantenido estable, 512 lleva pagando dividendos menos de 10 años.
Dividendo creciente: El pago de dividendos de 512 ha aumentado, pero la empresa sólo ha pagado dividendos durante 5 años.
Rentabilidad por dividendo vs. Mercado
| Rentabilidad por dividendo de Grand Pharmaceutical Group vs. Mercado |
|---|
| Segmento | Rentabilidad por dividendo |
|---|---|
| Empresa (512) | 5.3% |
| Suelo de mercado 25% (HK) | 3.2% |
| Techo de mercado 25% (HK) | 7.6% |
| Media de la industria (Pharmaceuticals) | 3.3% |
| Previsión de analistas en 3 años (512) | 6.8% |
Dividendo destacado: El dividendo de 512(6.1%) es más alto que el 25% inferior de los pagadores de dividendos del mercado Hong Kong (3.39%).
Alto dividendo: El (6.1%) del dividendo de 512 es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado Hong Kong (8.24%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (48.5%), los pagos de dividendos de 512 están bien cubiertos por los beneficios.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: Con su razonablemente bajo ratio de pago en efectivo (47%), los pagos de dividendos de 512 están bien cubiertos por los flujos de caja.